SpaceX: You Are Buying 2030 At The 2026 Offer Price

The article argues SpaceX is significantly overvalued at $135 per share, implying a roughly $1.77T market cap versus a probability-weighted fair value of $91. Starlink is presented as the main value driver, with $7.2B of segment EBITDA in 2025 and a strong quasi-monopoly position, but xAI is flagged as a major risk, burning about $1B per month with governance and capital allocation concerns for outside shareholders.

Analysis

The market is implicitly underwriting a near-perfect execution path where the high-quality asset becomes the financing engine for everything else, but that structure is fragile. The core issue is not whether the flagship can compound; it is whether minority holders in a public wrapper get enough claim on that compounding after governance leakage, reinvestment intensity, and opportunistic capital allocation. In that setup, the discount rate should be materially higher than for a normal IPO because investors are not just buying operating risk—they are buying agency risk.

The second-order loser is the broader late-stage private tech complex. If this deal prices rich and then trades poorly, it raises the hurdle for other “founder-control + moonshot optionality” listings and could compress clearing multiples across frontier AI and space-adjacent private marks. That matters for VC/PE portfolios because paper valuation support has been increasingly dependent on cross-asset narrative comparables rather than cash yield; a failed public market validation would force more realistic marks over the next 2-3 quarters.

The main catalyst sequence is likely to be quarterly, not daily: initial enthusiasm can persist until the market starts separating asset quality from capital allocation quality. Any acceleration in burn or any evidence that the low-quality venture drags on upstream funding would likely widen the holdco discount quickly. Conversely, the only durable bull case is ring-fencing: hard governance protections, explicit capital discipline, and proof that high-ROI projects are funded without cross-subsidizing speculative spend.

Contrarianly, the market may be underestimating the value of the portfolio’s embedded call options if governance is cleaner than feared and the public listing creates a monetization currency for selective asset sales. But that is an execution story, not a valuation story—at the current price, investors are paying for a best-case outcome before the burden of proof has shifted.

Key Decisions for Investors

• Avoid long exposure into the IPO; if a mandate forces participation, use a small-size starter only after the first post-listing filing cycle confirms governance and segment reporting clarity.
• If liquid borrow exists post-IPO, consider a tactical short against an AI/space basket long over 1-3 months to isolate valuation compression from sector beta; target is holdco discount expansion if sentiment normalizes.
• Prefer owning public AI beneficiaries with clearer capital discipline over the IPO for the next 6-12 months; the risk/reward is superior because they monetize demand without balance-sheet leakage.
• For private-mark exposure, reduce marks on late-stage frontier AI names by 10-20% if the IPO is poorly received, as secondary comps will likely reset over the following quarter.
• If the stock trades below the implied fair value range after lock-up/first earnings, reassess for a mean-reversion long only if governance disclosures improve and non-core burn is demonstrably ring-fenced.